This may be an issue of an inferior control arm rather than a superior trial arm. The single most active class of agents in breast cancer is absent in both treatments. |
We're seeing death rates drop in major diseases now... We're seeing extraordinary scientific advances that are laying the foundation for truly revolutionary changes in the way cancer is managed. |